TXN Sherman Fab Live — $7.5B Silicon Labs Deal Now

TXN Sherman Fab Live — $7.5B Silicon Labs Deal Now

Introduction

This week brought several hard developments that directly affect Texas Instruments (TXN) investors: the Sherman SM1 300mm fabrication facility moved into production, management issued first-quarter guidance that topped consensus, and TI agreed to acquire Silicon Labs for about $7.5 billion in cash. Each item reduces uncertainty along different parts of TI’s transformation—from heavy capital spending to capacity-driven revenue growth—and has immediate implications for earnings, cash flow and strategic positioning.

What changed for TXN this week

1) Sherman SM1 fab begins production

TI announced that its Sherman SM1 300mm fab in Texas has transitioned from construction to production. That milestone matters because it converts months (and billions) of capital investment into usable wafer capacity capable of producing analog and mixed-signal die that feed TI’s industrial, automotive, medical and data center customers. Moving a fab from build to production is often the riskiest phase — but reaching this stage materially de-risks TI’s multi-fab rollout and shortens the timeline to revenue recognition from the investment.

2) Q1 guidance topped expectations

Management set Q1 revenue guidance in a range of $4.32 billion to $4.68 billion with EPS guidance of $1.22 to $1.48. That outlook was received positively by analysts and helped prompt several target upgrades. On the tape earlier in the week TXN traded in the low- to mid-$220s (closing near $223 on February 12 after modest intraday weakness). The combination of firmer guidance and visible factory production supports a thesis of improving order flow in TI’s key end-markets.

3) $7.5B Silicon Labs acquisition

TI agreed to buy Silicon Labs for approximately $7.5 billion in cash, or roughly $231 per share, with the deal expected to close in the first half of 2027 pending regulatory approvals and shareholder consent. Management projects roughly $450 million of annual synergies three years after close. For TXN shareholders this is a tangible, near-term source of incremental revenue and product breadth — particularly in microcontrollers and connectivity products that can be routed through TI’s expanding U.S. capacity.

Why these developments matter to investors

From capex to capacity monetization

TI’s narrative for the past several years has centered on a large U.S. fab build-out. The Sherman production start is the most visible evidence that capex is converting into supply. That means the company can shift the story from heavy capital deployment to capacity utilization and margin improvement as production ramps and product qualifications complete.

Cash flow and capital allocation

With production underway and guidance above estimates, free cash flow visibility improves. The Silicon Labs acquisition is cash-based and accompanied by synergy targets, which suggests management expects the combined business to generate returns that justify the purchase while maintaining dividend and buyback flexibility. Analyst houses responded with price-target raises (examples include Bank of America and TD Cowen raising targets into the mid-$200s), reflecting improved near-term earnings visibility.

Regulatory and integration risk remain

While the acquisition and fab start reduce certain risks, they introduce others. The Silicon Labs deal requires regulatory approvals and careful product-line integration. Separately, achieving high utilization at Sherman will take time; fabs typically ramp through qualification, low-volume production, and then steady-state output. Execution will determine whether the investments quickly translate into the projected $450 million of synergies and higher revenue.

Key data points and investor implications

• Q1 revenue guidance: $4.32B–$4.68B; EPS guidance: $1.22–$1.48.
• TXN share-price context (this week): trading in the low-to-mid $220s (closed near $223 on Feb. 12).
• Acquisition terms: ~$7.5B cash purchase of Silicon Labs at ~$231 per share; expected close in H1 2027; estimated $450M annual synergies within three years.
• Production milestone: Sherman SM1 300mm fab now producing wafers.

Analogy: turning a construction site into a factory floor

Think of TI’s recent progress like completing and opening a major new factory wing. Building the structure is costly and slow; opening it for production is when customers can actually buy the goods and management can show returns. The Silicon Labs deal is akin to signing a long-term tenant whose products can immediately occupy that new wing, reducing idle capacity risk and accelerating payback.

Conclusion

This week’s developments change the risk/return profile for TXN in concrete ways. The Sherman fab’s production start converts capex into capacity, the Q1 guidance shows demand traction, and the Silicon Labs acquisition provides an immediate revenue and product complement that can help fill new capacity. The near-term story is no longer solely about spending — it’s about execution: achieving high fab utilization, integrating Silicon Labs successfully, and realizing the stated synergies.

For investors focused on TXN, the next measurable milestones to watch are regulatory progress and closing of the Silicon Labs transaction, early utilization and product qualification metrics from Sherman, and whether subsequent quarters show margin improvement and cash-flow acceleration consistent with management’s guidance and synergy targets.

Disclosure

The article summarizes recent company announcements and analyst actions. Information is based on published reports and company guidance; investors should perform their own due diligence before making investment decisions.